У нас вы можете посмотреть бесплатно Tecentriq: Tips for continuing treatment when it’s working for you, with Gina M. Spradling или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In August 2021, Genentech, maker of the immunotherapy atezolizumab (Tecentriq), announced they would voluntarily withdraw the drug from its approved use to treat metastatic triple-negative breast cancers that express PD-L1. The decision was based on a clinical trial that showed adding atezolizumab to treatment with certain chemotherapy medicines did not improve survival. Still, many people now in treatment with atezolizumab are seeing positive results. To help you understand what this change of course could mean for you, Living Beyond Breast Cancer CEO Jean A. Sachs, MSS, MLSP, spoke with Hear My Voice advocate Gina M. Spradling, who was diagnosed with metastatic breast cancer in November 2020 and is now taking atezolizumab. In this video, Gina shares how she found out about the withdrawal, as well as what she learned by talking to Genentech and her oncologist. Gina offers tips for advocating for yourself if you want to continue treatment with atezolizumab when it’s working for you. Learn more at LBBC.ORG